A generic alternative indicated for Antibiotics. Precision targeting of infection-causing bacteria supports the body's natural defense mechanisms and alleviates localized inflammatory discomfort.
Indicated to address serious bacterial infections by targeting protein production to alleviate symptoms and mitigate the risk of severe complications in skin or tissues.
Mechanism of Action
Clindamycin binds to the bacterial ribosome and inhibits the synthesis of proteins. This prevents the bacteria from growing and spreading, which allows the host's immune system to destroy the remaining pathogens.
Route of Administration
Oral
Onset Time
1 hour
Duration
6–8 hours
Contraindications
History of pseudomembranous colitis, Hypersensitivity to lincosamides, Inflammatory bowel disease
Severe Adverse Events
Clostridioides difficile-associated diarrhea, Severe liver injury, Severe skin reactions, Kidney damage, Low white blood cell count
Information for Clindamycin is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
